On August 11, NEWGENE’s COVID-19 Antigen Detection Kit – Nasal Swab was registered by the South African Health Products Regulatory Authority (SAHPRA). South Africa is the most rigorous country in Africa for medical device approval, and it is also an important reference country for the registration of African countries. The successful passage of this registration shows that NEWGENE products have been fully recognized by the South African authorities.
South Africa is currently one of the countries with the worst COVID-19 epidemic in Africa, with nearly 10,000 new confirmed cases every day. Under the severe epidemic situation, NEWGENE products will effectively accelerate the epidemic prevention and anti-epidemic process in South Africa and contribute to the prevention and control of the epidemic in Africa.
Post time: Aug-12-2021